Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT04150107 | A Study to Compare ORMD-0801 Once Daily to ORMD-0801 Three Times Daily in Subjects With Type 1 Diabetes | PHASE2 | COMPLETED | 30 | — | — | Oct 1, 2019 | Mar 1, 2020 | Jun 1, 2022 | - | — |
| Name | Type | Description |
|---|---|---|
| ORMD-0801 Treatment A | DRUG | Treatment A: 24 mg (16 mg capsule + 8 mg capsule) Once Daily (QD) at bedtime |
| ORMD-0801 Treatment B | DRUG | Treatment B: 8 mg (8 mg capsule) three times a day (TID) 45-90 minutes before meals |
| Placebo | OTHER | Fish oil capsule |